A Multi-Center, Prospective, Observational Study of Patients Being Treated With ORGOVYX

Cancer Recurrence, Clinical Trials, High Risk Prostate Cancer, Intermediate Risk Prostate Cancer, Metastatic Castration Sensitive Prostate Cancer (MCSPC)

— PHENTrials.com Increasing Participation in Prostate Cancer Clinical Trials to Save Lives

NCT Number: NCT05467176
Phase:
Trial Summary: This is a multi-center, prospective, observational study of patients being treated with ORGOVYX. The goal of this study is to generate real-world evidence about the safety and effectiveness of ORGOVYX – clinicaltrials.gov for more information and location
Clinicaltrials.gov
Trial Sponsor(s): Myovant Sciences GmbH
Acronym: OPTYX

Pin It on Pinterest